 Home > Medical News > Latest Medical News > Genting Xinyao submits a new drug marketing authorization application for goxatuzumab in Hong Kong, China

Genting Xinyao submits a new drug marketing authorization application for goxatuzumab in Hong Kong, China

 Last Update: 2022-05-26
 Source: Internet
 Author: User

Tags

isotretinoin brand name

clonidine brand name

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 31, Genting Sunyao announced that it had submitted a New Drug Application (NDA) for sacituzumab govitecan to the Department of Health of the Hong Kong Special Administrative Region of China for the treatment of patients who have received at least two prior systemic treatments (including Adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) with at least one treatment for metastatic disease)

In addition, regulatory agencies or drug administrations in mainland China, South Korea, and Taiwan have successively accepted the marketing applications of goxatuzumab for the treatment of patients who have received at least two previous systemic therapies (at least one of which is for metastatic disease).

In November 2021, Genting Sunyao announced top-line results from the Phase 2b study of goxatuzumab, EVER-132-001, which met its primary endpoint with an objective response rate (ORR) of 38.

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.